MAPT and Alzheimer disease: Interestingly, consistent with these results, this inhibitor has previously been shown to completely block the oAβ-induced loss of dendritic spine density and impaired LTP in vitro in cultured neurons34, and prevent tau phosphorylation in vivo and behavioral impairments in an AD mouse model50.